Kyungdong Pharm경동제약
011040 · KOSDAQ · ₩011040 · 경동제약
₩4,850▼ ₩65 (1.32%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 60.7% | 59.7% | 59.0% | 55.0% | 52.6% | 55.3% |
| Operating margin | 5.9% | 3.9% | 1.4% | −15.3% | 4.5% | 8.9% |
| Net margin | 8.9% | 4.3% | 2.8% | −12.7% | 6.7% | 7.1% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +2.5% | +1.2% | +19.2% | −11.0% | +2.9% | — |
| Operating income growth | +53.6% | +192.2% | +110.5% | −400.2% | −47.2% | — |
| Net income growth | +109.1% | +55.9% | +126.4% | −270.3% | −4.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 7.8% | 3.8% | 2.4% | −8.5% | 4.7% | 4.9% |
| Return on assets | 4.6% | 2.7% | 1.8% | −6.9% | 4.0% | 4.3% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 32.9% | 40.6% | 37.5% | 28.2% | 20.6% | 12.2% |
| Net debt to equity | 5.3% | 5.8% | 10.4% | 1.4% | 3.7% | −6.8% |
| Current ratio | 176.6% | 162.0% | 129.8% | 152.0% | 205.4% | 406.9% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Kyungdong Pharm / 경동제약 / 011040 / KRX:011040
Source: KRX statistical information